Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Nature Methods|June 27, 2018
A reassessment of DNA-immunoprecipitation-based genomic profilingAntonio Lentini, Cathrine Lagerwall, Svante Vikingsson, et al.
Pharmacogenomics|June 27, 2015
Role of cytochrome P450 2C8*3 (CYP2C8*3) in paclitaxel metabolism and paclitaxel-induced neurotoxicityMi-Young Lee, María Apellániz-Ruiz, Inger Johansson, et al.
Journal of Analytical Toxicology|August 30, 2022
Performance of Hair Testing for Cocaine Use-Comparison of Five Laboratories Using Blind Reference SpecimensE Dale Hart, Svante Vikingsson, Ruth E Winecker, et al.
Journal of Analytical Toxicology|March 9, 2022
Prevalence of Cannabidiol, ∆9- and ∆8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine SpecimensSvante Vikingsson, Ruth E Winecker, Edward J Cone, et al.
Journal of Analytical Toxicology|September 12, 2023
Prevalence of ∆8-tetrahydrocannabinol carboxylic acid in workplace drug testingSvante Vikingsson, E Dale Hart, Ruth E Winecker, et al.
Journal of Analytical Toxicology|February 1, 2024
Fentanyl as a marker of illicit drug use in morphine-positive urine specimens from workplace drug testingSvante Vikingsson, Ruth E Winecker, David J Kuntz, et al.
Acta Pharmacologica Sinica|November 3, 2025
Structure-activity relationship of prevalent synthetic cannabinoid metabolites on hCB1 in vitro and in silico dynamicsAnna Åstrand, Emiliano Laudadio, Prince S Gameli, et al.
Molecular Cancer Therapeutics|February 2, 2011
Increased sensitivity to thiopurines in methylthioadenosine phosphorylase-deleted cancersSally A Coulthard, Christopher P F Redfern, Svante Vikingsson, et al.
Journal of Analytical Toxicology|November 8, 2025
Cannabidiol metabolites identified by LC-QTOF after controlled dosingSvante Vikingsson, Ruth E Winecker, Katherine Bollinger, et al.
Pageof 7